Last update 08 May 2025

GPR19 Antagonists(Omeros)

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms-
Target
GPR19
Action
antagonists
Mechanism
GPR19 antagonists(G protein-coupled receptor 19 antagonists)
Therapeutic Areas
NeoplasmsRespiratory DiseasesSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Lung CancerMetastatic melanoma
Originator Organization
Omeros Corp.Omeros Corp.
Active Organization-
Inactive Organization
Omeros Corp.Omeros Corp.
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with GPR19 Antagonists(Omeros)
Login to view more data
100 Translational Medicine associated with GPR19 Antagonists(Omeros)
Login to view more data
100 Patents (Medical) associated with GPR19 Antagonists(Omeros)
Login to view more data
100 Deals associated with GPR19 Antagonists(Omeros)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lung CancerPreclinical
United States
Omeros Corp.Omeros Corp.
30 Nov 2011
Metastatic melanomaPreclinical
United States
Omeros Corp.Omeros Corp.
30 Nov 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free